Vertex Pharmaceuticals news
Results Vertex Pharmaceuticals has filed with the SEC, each with its AAOIFI halal screening.
- Vertex Pharmaceuticals reports $3.44 billion revenue for quarter ended September 30, 2026, up 11.8%
- Vertex Pharmaceuticals reports $3.33 billion revenue for quarter ended June 30, 2026, up 12.5%
- Vertex Pharmaceuticals reports $2.99 billion revenue for quarter ended March 31, 2026, up 7.8%
- Vertex Pharmaceuticals reports $12 billion revenue for fiscal year ended December 31, 2025, up 8.9%
Recent event reports (Form 8-K)
- Announced results of operations
- Director or senior officer change
- Director or senior officer change
- Announced results of operations
- Entered a material agreement
- Director or senior officer change
- Announced results of operations
- Director or senior officer change
- Announced results of operations
- Announced results of operations
Listed from the company's filing index on the SEC website; open the filing for the details.